MOLCUREMOLCUREMOLCUREMOLCURE
  • News
  • Technologies
  • About Us
MOLCUREMOLCUREMOLCUREMOLCURE
  • Contact
  • Recruit
  • 🌐 lang
    • 日本語
    • English
  • 2023-01-06
  • Business, Technology

Our CSO, Satoshi Tamaki, will speak at the 17th RIKEN Symposium on January 11th.
He will introduce MOLCURE’s Antibody/Peptide Drug Discovery Platform using AI and Laboratory automation.
The lecture will be in Japanese and begins at 15:55.
We look forward to seeing you there.

Link (Japanese only): http://www2.riken.jp/nano-med.eng.lab/bio-mono17.html

Previous Post
Newer Post

Similar Blog Posts

MOLCURE to Present at Kick-off Event for the National Cancer Center Tsuruoka Collaborative Research Center’s Third-Phase Project, October 13

MOLCURE to Present at Kick-off Event for the National Cancer Center Tsuruoka Collaborative Research Center’s Third-Phase Project, October 13

Read more
国立がん研究センター・鶴岡連携研究拠点 第3期プロジェクト キックオフイベントに登壇, October 13

国立がん研究センター・鶴岡連携研究拠点 第3期プロジェクト キックオフイベントに登壇, October 13

Read more
BioJapan 2026: MOLCURE to Speak at iPark Institute and Johnson & Johnson Session, October 9

BioJapan 2026: MOLCURE to Speak at iPark Institute and Johnson & Johnson Session, October 9

Read more
BioJapan 2026でアイパークインスティチュート・Johnson & Johnson共催セッションに登壇, October 9

BioJapan 2026でアイパークインスティチュート・Johnson & Johnson共催セッションに登壇, October 9

Read more
  • contact [AT] molcure.io
  • 本社:〒212-0032 神奈川県川崎市幸区新川崎7-7 AIRBIC
  • バイオラボ:〒997-0052 山形県鶴岡市覚岸寺字水上246−2

Map_Kawasaki

Map_Turuoka

© MOLCURE Inc.
MOLCURE
  • News
  • Technologies
  • About Us